Table 2.

Multivariable analysis in ADEB-treated patients for OS, EFS, and RR.

OS from study entryEFS from study entryRR from end of course 2
nHR95% CIPHR95% CIPnHR95% CIP
HSF1-pSer326            
 Low 52     48   
 Middle 83 2.10 0.89-4.95 .090 1.92 1.07-3.43 .028 70 1.60 0.84-3.04 .156 
 High 69 3.58 1.56-8.22 .003 2.94 1.65-5.24 <.001 60 2.76 1.45-5.29 .002 
Risk group            
 Low 155     146   
 High 49 2.66 1.55-4.58 <.001 2.18 1.42-3.34 <.001 32 1.48 0.82-2.66 .194 
OS from study entryEFS from study entryRR from end of course 2
nHR95% CIPHR95% CIPnHR95% CIP
HSF1-pSer326            
 Low 52     48   
 Middle 83 2.10 0.89-4.95 .090 1.92 1.07-3.43 .028 70 1.60 0.84-3.04 .156 
 High 69 3.58 1.56-8.22 .003 2.94 1.65-5.24 <.001 60 2.76 1.45-5.29 .002 
Risk group            
 Low 155     146   
 High 49 2.66 1.55-4.58 <.001 2.18 1.42-3.34 <.001 32 1.48 0.82-2.66 .194 

HR, hazard ratio.

or Create an Account

Close Modal
Close Modal